Disease_category,Disease,Protein,Protein_definition,method,nsnp,OR [95% CI],Pvalue,QTL_type
Chapter XIII Diseases of the musculoskeletal system and connective tissue,M13_TENDOSYNOVITISNAS,RRM2,Ribonucleoside-diphosphate reductase subunit M2,Wald ratio,1,1.35 [0.53-3.46],0.527405853288765,cis
Chapter XIII Diseases of the musculoskeletal system and connective tissue,M13_TENDOSYNOVITISNAS,GDF15,Growth/differentiation factor 15,Inverse variance weighted,12,0.97 [0.71-1.32],0.848293349983978,cis
Chapter XIII Diseases of the musculoskeletal system and connective tissue,M13_TENDOSYNOVITISNAS,CHGA,Chromogranin-A,Inverse variance weighted,3,0.98 [0.78-1.24],0.870432515115455,cis
Chapter XIII Diseases of the musculoskeletal system and connective tissue,M13_TENDOSYNOVITISNAS,VSIG2,V-set and immunoglobulin domain-containing protein 2,Inverse variance weighted,5,1.01 [0.83-1.24],0.892588725700685,cis
Chapter XIII Diseases of the musculoskeletal system and connective tissue,M13_TENDOSYNOVITISNAS,TNFRSF1B,Tumor necrosis factor receptor superfamily member 1B,Inverse variance weighted,4,1.01 [0.69-1.48],0.958520168354549,cis
Chapter XIII Diseases of the musculoskeletal system and connective tissue,M13_TENDOSYNOVITISNAS,GDF15,Growth/differentiation factor 15,Wald ratio,1,2.18 [0.56-8.56],0.262262131070645,trans
Chapter XIII Diseases of the musculoskeletal system and connective tissue,M13_TENDOSYNOVITISNAS,CHGA,Chromogranin-A,Inverse variance weighted,5,0.96 [0.68-1.36],0.83222843715534,trans
Chapter XIII Diseases of the musculoskeletal system and connective tissue,M13_TENDOSYNOVITISNAS,TNFRSF1B,Tumor necrosis factor receptor superfamily member 1B,Inverse variance weighted,5,0.97 [0.57-1.65],0.92300520228715,trans
